News on Aalto Bio Reagents Ltd from BioPortfolio.com http://www.BioPortfolio.com Consolidated Aalto Bio Reagents Ltd news from BioPortfolio.com Wed, 10 Feb 2010 06:56:15 GMT en LTT Bio-Pharma Co., Ltd-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027645&HITNO=0&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Aalto%20Bio%20Reagents%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027645&THISHREF=http://c.moreover.com/click/here.pl%3fz2532271974%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027645&HITNO=0&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Aalto%20Bio%20Reagents%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027645&THISHREF=http://c.moreover.com/click/here.pl%3fz2532271974%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Genovate Biotechnology Co., Ltd. (GBL)-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028719&HITNO=1&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Aalto%20Bio%20Reagents%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028719&THISHREF=http://c.moreover.com/click/here.pl%3fz2532827511%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028719&HITNO=1&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Aalto%20Bio%20Reagents%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028719&THISHREF=http://c.moreover.com/click/here.pl%3fz2532827511%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Actelion Pharmaceuticals Ltd (CH) - Actelion to Present at the 12th Annual BIO CEO & Investor Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024881&HITNO=2&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Aalto%20Bio%20Reagents%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024881&THISHREF=http://c.moreover.com/click/here.pl%3fz2529256857%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024881&HITNO=2&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Aalto%20Bio%20Reagents%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024881&THISHREF=http://c.moreover.com/click/here.pl%3fz2529256857%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: HTDS announces recent business developmentshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024797&HITNO=3&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Aalto%20Bio%20Reagents%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024797&THISHREF=http://c.moreover.com/click/here.pl%3fz2529190545%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024797&HITNO=3&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Aalto%20Bio%20Reagents%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024797&THISHREF=http://c.moreover.com/click/here.pl%3fz2529190545%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Thrombotech to begin Phase I trial of stroke treatment: The safety trial of the peptide will test its possiblehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019183&HITNO=4&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Aalto%20Bio%20Reagents%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019183&THISHREF=http://c.moreover.com/click/here.pl%3fz2526168051%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019183&HITNO=4&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Aalto%20Bio%20Reagents%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019183&THISHREF=http://c.moreover.com/click/here.pl%3fz2526168051%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRBC Dain Rauscher: Phoenix Technologies Files Patent Infringement Lawsuit Against DeviceVMhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020491&HITNO=5&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Aalto%20Bio%20Reagents%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020491&THISHREF=http://c.moreover.com/click/here.pl%3fz2526803089%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020491&HITNO=5&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Aalto%20Bio%20Reagents%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020491&THISHREF=http://c.moreover.com/click/here.pl%3fz2526803089%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRBC Dain Rauscher: LevelStock.com: Phoenix Technologies Files Patent Infringement Lawsuit Against DeviceVMhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020495&HITNO=6&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Aalto%20Bio%20Reagents%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020495&THISHREF=http://c.moreover.com/click/here.pl%3fz2526804123%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020495&HITNO=6&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Aalto%20Bio%20Reagents%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020495&THISHREF=http://c.moreover.com/click/here.pl%3fz2526804123%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRBC Dain Rauscher: Hard to Treat Diseases (HTDS) Update On Various Business Developments Evaluations and Proposalshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022705&HITNO=7&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Aalto%20Bio%20Reagents%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022705&THISHREF=http://c.moreover.com/click/here.pl%3fz2527813275%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022705&HITNO=7&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Aalto%20Bio%20Reagents%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022705&THISHREF=http://c.moreover.com/click/here.pl%3fz2527813275%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInterest!ALERT: Techpool Bio-Pharma Co., LTD.-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015720&HITNO=8&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Aalto%20Bio%20Reagents%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015720&THISHREF=http://c.moreover.com/click/here.pl%3fz2524498684%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015720&HITNO=8&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Aalto%20Bio%20Reagents%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015720&THISHREF=http://c.moreover.com/click/here.pl%3fz2524498684%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: XOMA Announces Presentation at BIO CEO and Investor Conference on February 9http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010161&HITNO=9&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Aalto%20Bio%20Reagents%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010161&THISHREF=http://c.moreover.com/click/here.pl%3fz2522271381%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010161&HITNO=9&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Aalto%20Bio%20Reagents%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010161&THISHREF=http://c.moreover.com/click/here.pl%3fz2522271381%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: ImmunoCellular Therapeutics to Present at 12th Annual BIO CEO & Investor Conference on Tuesday, February 9thhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013221&HITNO=10&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Aalto%20Bio%20Reagents%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013221&THISHREF=http://c.moreover.com/click/here.pl%3fz2523657237%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013221&HITNO=10&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Aalto%20Bio%20Reagents%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013221&THISHREF=http://c.moreover.com/click/here.pl%3fz2523657237%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: ImmunoCellular Therapeutics to Present at 12th Annual BIO CEO & Investor Conference on Tuesday, February 9thhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013202&HITNO=11&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Aalto%20Bio%20Reagents%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013202&THISHREF=http://c.moreover.com/click/here.pl%3fz2523652064%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013202&HITNO=11&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Aalto%20Bio%20Reagents%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013202&THISHREF=http://c.moreover.com/click/here.pl%3fz2523652064%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: ImmunoCellular Therapeutics to Present at 12th Annual BIO CEO & Investor Conference on Tuesday, February 9thhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013463&HITNO=12&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Aalto%20Bio%20Reagents%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013463&THISHREF=http://c.moreover.com/click/here.pl%3fz2523725903%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013463&HITNO=12&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Aalto%20Bio%20Reagents%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013463&THISHREF=http://c.moreover.com/click/here.pl%3fz2523725903%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: ImmunoCellular Therapeutics to Present at 12th Annual BIO CEO & Investor Conference on Tuesday, February 9thhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013424&HITNO=13&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Aalto%20Bio%20Reagents%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013424&THISHREF=http://c.moreover.com/click/here.pl%3fz2523718021%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013424&HITNO=13&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Aalto%20Bio%20Reagents%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013424&THISHREF=http://c.moreover.com/click/here.pl%3fz2523718021%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: ImmunoCellular Therapeutics to Present at 12th Annual BIO CEO & Investor Conference on Tuesday, February 9thhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016307&HITNO=14&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Aalto%20Bio%20Reagents%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016307&THISHREF=http://c.moreover.com/click/here.pl%3fz2524710179%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016307&HITNO=14&MSIZE=131&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Aalto%20Bio%20Reagents%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016307&THISHREF=http://c.moreover.com/click/here.pl%3fz2524710179%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: